Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

180.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 248.00
  • 52 Week Low: 147.50
  • Currency: UK Pounds
  • Shares Issued: 46.32m
  • Volume: 2,000
  • Market Cap: 83.38m
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-18 Interim 25.34 (2.85) (6.60)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 21.16 0.78 2.40p 63.5 n/a n/a n/a 0.0%
31-Dec-15 30.18 2.07 9.50p 17.8 0.1 +296% n/a 0.0%
31-Dec-16 39.23 (0.22) 6.80p 22.4 n/a -28% n/a 0.0%
31-Dec-17 47.62 (4.45) 4.20p 43.7 n/a -38% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 53.94 0.55 1.22p 148.4 n/a -71% n/a 0.0%
31-Dec-19 61.28 5.32 9.54p 19.0 0.0 +682% n/a 0.0%
31-Dec-20 67.97 7.59 13.18p 13.7 0.4 +38% n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 43.69 17.84 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Ergomed Market Data

Currency UK Pounds
Share Price 180.00p
Change Today -1.00p
% Change -0.55 %
52 Week High 248.00
52 Week Low 147.50
Volume 2,000
Shares Issued 46.32m
Market Cap 83.38m
Beta 0.00

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.05% below the market average68.05% below the market average68.05% below the market average68.05% below the market average68.05% below the market average
69.49% below the sector average69.49% below the sector average69.49% below the sector average69.49% below the sector average69.49% below the sector average
Price Trend
11.54% above the market average11.54% above the market average11.54% above the market average11.54% above the market average11.54% above the market average
34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average34.43% above the sector average
Income Not Available
Growth
29.50% above the market average29.50% above the market average29.50% above the market average29.50% above the market average29.50% above the market average
26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average26.32% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 18-Apr-2019

Time Volume / Share Price
11:00 2,000 @ 182.00p

Ergomed Key Personnel

COO Jan Petracek
CFO Stuart Jackson

Top of Page